Navigation Links
AACR, BCRF award inaugural grants in translational breast cancer research
Date:10/11/2007

PHILADELPHIA Through the generous support of the Breast Cancer Research Foundation (BCRF), the American Association for Cancer Research (AACR) is pleased to announce the inaugural recipients of the 2007 BCRF-AACR Grants in Translational Breast Cancer Research. These grants provide direct support for innovative breast cancer research projects designed to accelerate the discovery, development, and application of new ways to treat breast cancer, or for preclinical research with direct therapeutic implications.

After careful evaluation and assessment by an esteemed scientific review committee, three researchers emerged as the winners of the 2007 BCRF-AACR Grants in Translational Breast Cancer Research. They are: Ingrid A. Mayer, M.D., Assistant Professor of Medicine Vanderbilt University Medical Center; Alana Welm, Ph.D., Assistant Professor of Oncological Sciences at the Huntsman Cancer Institute, University of Utah; and Douglas Yee, M.D., Cancer Center Director and Professor, University of MinnesotaTwin Cities.

The AACR congratulates Drs. Mayer, Welm and Yee on this outstanding achievement and applauds their efforts to translate their innovative research into potential treatments for breast cancer, said Margaret Foti, Ph.D., M.D. (h.c.), AACRs chief executive officer. We are deeply grateful to the Breast Cancer Research Foundation for its commitment to cutting-edge breast cancer research and look forward to a long-lasting partnership in supporting novel translational research.

Currently, an estimated 2 million Americans are living with or have been treated for breast cancer. Approximately 178,480 new breast cancer cases will be diagnosed this year, and about 40,460 will die from the disease. Translational research bridges the gap between laboratory research and patient care. The BCRF-AACR grant program has the vitally important goal of bringing scientific discoveries from the laboratory into breast cancer treatmen
'/>"/>

Contact: Jennifer Ryan
jennifer.ryan@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. NJIT Presidential Award winner takes stem cell research another step
2. TGen awarded $7.1 million to accelerate brain disease research
3. Virtual microscopy project wins educational technology award
4. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
5. Asian immigrants in NYC not receiving HIV education at religious institutions
6. Scientists win grants to develop $1,000 genome sequencing technology
7. Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance
8. A splice of the action: Translational role for WT1 isoform
9. Viral DNA sequence a possible trigger for breast cancer
10. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
11. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...A, NOVEMBER 9, 2009 A nutritionist whose researc... to the federal Women, Infants and Children (WIC) ... Higgins Award for outstanding achievement in the ...ison, Ph.D., MNS, , a professor in the Department ...California, Los Angeles School of Public Health, w...
(Date:11/8/2009)...AYETTE, Ind. - Researchers at Purdue University ha... nerve fibers in spinal cord injuries using nano-s...ly after an accident. , The synthetic "copolymer...meters in diameter, or roughly 100 times smaller t...ers have been studying how to deliver drugs for ca...
(Date:11/8/2009)...- (Nov. 8, 2009) The loss of a gene through delet...ated with significant abnormalities in learning an...y Baylor College of Medicine ( www.bcm.edu ) in a ...ature Genetics . , "This research goes about 95 ...specific group of individuals to this gene," said ...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Developmental delay could stem from nicotinic receptor deletion 2MU study finds connection between evolution classroom learning 8764 1MU study finds connection between evolution classroom learning 8764 2Revitalized Village Sparkles in the North Country 48294 1Revitalized Village Sparkles in the North Country 48294 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
...rrent issue of CELL TRANSPLANTATION (Vol. 17:4) fe...king new ways to treat Parkinsons disease (PD), a ...ity, tremor and slowed physical movements related ...al ganglia of the brain, by using primate models t...ed cells. , One research team looked at the abili...
...and Technology (NIST) has developed Standard Refer... in folk medicine and now increasingly used in her...new materials to develop and test analytical metho...aterials for quality assurance of their measuremen...nce to address the use of bitter orange for health...
...l of Forest Research presents the preliminary find... landscape-scale experiments on how forest managem...The Blacks Mountain Interdisciplinary Research tea...versity, Oregon State University, U.C. Riverside, ...ciety scientists collaborating in research on larg...
Other Biology News:Neural cell transplants may help those with Parkinson's disease 2Neural cell transplants may help those with Parkinson's disease 3Bitter orange SRMs: Tools for product analysis/quality 2Pioneering landscape-scale research releases first findings 2
(Date:11/9/2009)... Four of the top 10 pharmaceutical... submissions to Health Canada. Datafarm’s an... 7th Canadian DIA Annual Meeting where Health Cana...panies may submit Hybrid eCTD regulatory submissio... no prior permission request. , ...
(Date:11/9/2009)... Product release is a research ind..., research facilities and research safety study da... Cedar Knolls, NJ (PRWEB) No... today that it has unveiled Pristima™ VM, an...rch facilities that track the use and care of vete...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/8/2009)...r 6, 2009 As global temperatures and energy costs...l be key to a sustainable future. An attractive ...udies published online in Genome Research ( www....structures of bioethanol-producing microorganisms,... developing new technologies needed to implement p...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
...ution Agreement, GURGAON, India and PRINCETON, N....a wholly owned subsidiary of Ranbaxy,Laboratories ... several,agreements with AstraZeneca. Two of these...s. The third agreement pertains to Omeprazole 40mg...odipine ER capsules. All,of the agreements are spe...
...us, Inc.,today announced the appointment of Fisher...its new automated PLAC Test for the Hitachi, Hitac... to U.S. hospital clinical,laboratories. The new a...ood & Drug Administration (FDA) enabling the test ...rs., The PLAC Test is the only blood test cleared...
...asdaq: BNVI ) will present findings on the mechan...07 and BN108 at the American Association of,Cancer...ntion Center in San,Diego, CA, April 12 - 16, 2008...e pathway for cancer cell,apoptosis (cell death) i...a,Shtivelman, Director of Cancer Research at Biono...
Other Biology Technology:Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 2Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation 3diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 2diaDexus Selects Fisher HealthCare to Sell New Automated PLAC(R) Test 3Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research 2
Calf Serum, Iron-Supplemented from Sigma-Aldrich
...NA Polymerase is a thermostable DNA polymerase der...ty at temperatures above 70°C, it was the fir...e predominant enzyme for that purpose. The enzyme ...ease activity, but lacks 3'--5' proofreading exonu...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Abcam
...radient system uses three Adept CE 4100 high pres... in one microlitre increaments. The Adept CE 4200...System control and data processing is provided by ... unit, CE 4900., Column heater/chillers can be su...
Biology Products: